Molecular assays for the detection of microRNAs in prostate cancer
<p>Abstract</p> <p>Background</p> <p>MicroRNAs (miRNAs) are small non-coding RNAs (about 21 to 24 nucleotides in length) that effectively reduce the translation of their target mRNAs. Several studies have shown miRNAs to be differentially expressed in prostate cancer, m...
Main Authors: | Becker Michael M, Majlessi Mehrdad, Fleischer Chad L, Nelson Luke J, Siva Amara C, Vessella Robert L, Reynolds Mark A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-03-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/8/1/17 |
Similar Items
-
MicroRNAs in prostate cancer
by: Won Tae Kim, et al.
Published: (2013-03-01) -
Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
by: Nikhil Sapre, et al.
Published: (2013-01-01) -
MicroRNAs deregulation in prostate cancer
by: João António Ramalho Carvalho
Published: (2019) -
Interbase-FRET binding assay for pre-microRNAs
by: Mattias Bood, et al.
Published: (2021-04-01) -
MicroRNAs as Prognostic Biomarkers in Prostate Cancer
by: Gordanpour, Aida
Published: (2012)